Agitation Clinical Trials in London, Ontario
2 recruitingLondon, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
Nabilone for Agitation Blinded Intervention Trial
Alzheimer DiseaseAgitation
Sunnybrook Health Sciences Centre112 enrolled6 locationsNCT04516057